Animal models of Epstein Barr virus infection

Journal of Immunological Methods

Volumn 410, Issue , 2014, Pages 80-87

  Chatterjee, Bithi ^a   Leung, Carol Sze ^a   Münz, Christian ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Dendritic cells; Humanized mice; Infectious mononucleosis; Lymphoproliferative disease; NK cells; T cells

Indexed keywords

VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANIMAL MODEL; ARTICLE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; HAPLORHINI; IMMUNE SYSTEM; IMMUNOBIOLOGY; INNATE IMMUNITY; LYMPHOCRYPTOVIRUS; NONHUMAN; ANIMAL; BIOLOGICAL MODEL; DENDRITIC CELL; DISEASE MODEL; EPSTEIN BARR VIRUS; HUMAN; HUMANIZED MICE; IMMUNOLOGY; LYMPHOPROLIFERATIVE DISEASE; METABOLISM; MONONUCLEOSIS; MOUSE; NK CELLS; PATHOLOGY; T LYMPHOCYTE;

DENDRITIC CELLS; HUMANIZED MICE; INFECTIOUS MONONUCLEOSIS; LYMPHOPROLIFERATIVE DISEASE; NK CELLS; T CELLS;

ANIMALS; DISEASE MODELS, ANIMAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MODELS, IMMUNOLOGICAL;

EID: 84908509742     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.04.009     Document Type: Article

References (71)

1. Babcock G.J., Decker L.L., Volk M., Thorley-Lawson D.A. EBV persistence in memory B cells in vivo. Immunity 1998, 9:395.
2. Babcock J.G., Hochberg D., Thorley-Lawson A.D. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000, 13:497.
3. Barton E., Mandal P., Speck S.H. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 2011, 29:351.
4. Bickham K., Goodman K., Paludan C., Nikiforow S., Tsang M.L., Steinman R.M., Münz C. Dendritic cells initiate immune control of Epstein-Barr virus transformation of B lymphocytes in vitro. J. Exp. Med. 2003, 198:1653.
5. Billerbeck E., Horwitz J.A., Labitt R.N., Donovan B.M., Vega K., Budell W.C., Koo G.C., Rice C.M., Ploss A. Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J. Immunol. 2013, 191:1753.
6. Biron C.A., Byron K.S., Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989, 320:1731.
7. Chijioke O., Müller A., Feederle R., Barros M.H., Krieg C., Emmel V., Marcenaro E., Antsiferova O., Landtwing V., Bossart W., Moretta A., Hassan R., Boyman O., Niedobitek G., Delecluse H.J., Capaul R., Münz C. Natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep. 2013, 5:1489.
8. -/- mice as a model for Epstein-Barr virus infection. Am. J. Pathol. 2008, 173:1369.
9. Cohen J.I., Fauci A.S., Varmus H., Nabel G.J. Epstein-Barr virus: an important vaccine target for cancer prevention. Sci. Transl. Med. 2011, 3:107fs7.
10. Covassin L., Jangalwe S., Jouvet N., Laning J., Burzenski L., Shultz L.D., Brehm M.A. Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rgamma(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells. Clin. Exp. Immunol. 2013, 174:372.
11. Ehlers B., Dural G., Yasmum N., Lembo T., de Thoisy B., Ryser-Degiorgis M.P., Ulrich R.G., McGeoch D.J. Novel mammalian herpesviruses and lineages within the Gammaherpesvirinae: cospeciation and interspecies transfer. J. Virol. 2008, 82:3509.
12. Ehlers B., Spiess K., Leendertz F., Peeters M., Boesch C., Gatherer D., McGeoch D.J. Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus. J. Gen. Virol. 2010, 91:630.
13. Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964, 1:702.
14. Flano E., Woodland D.L., Blackman M.A. A mouse model for infectious mononucleosis. Immunol. Res. 2002, 25:201.
15. Fogg M.H., Kaur A., Cho Y.G., Wang F. The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue. J. Virol. 2005, 79:12681.
16. Fogg M.H., Garry D., Awad A., Wang F., Kaur A. The BZLF1 homolog of an Epstein-Barr-related gamma-herpesvirus is a frequent target of the CTL response in persistently infected rhesus macaques. J. Immunol. 2006, 176:3391.
17. Gorantla S., Makarov E., Finke-Dwyer J., Gebhart C.L., Domm W., Dewhurst S., Gendelman H.E., Poluektova L.Y. CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. J. Immunol. 2010, 184:7082.
18. Gottschalk S., Rooney C.M., Heslop H.E. Post-transplant lymphoproliferative disorders. Annu. Rev. Med. 2005, 56:29.
19. Gurer C., Strowig T., Brilot F., Pack M., Trumpfheller C., Arrey F., Park C.G., Steinman R.M., Münz C. Targeting the nuclear antigen 1 of Epstein Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 2008, 112:1231.
20. Harth-Hertle M.L., Scholz B.A., Erhard F., Glaser L.V., Dolken L., Zimmer R., Kempkes B. Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog. 2013, 9:e1003638.
21. Heuts F., Rottenberg M.E., Salamon D., Rasul E., Adori M., Klein G., Klein E., Nagy N. T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice. J. Virol. 2014, 88:3235.
22. Hjalgrim H., Askling J., Rostgaard K., Hamilton-Dutoit S., Frisch M., Zhang J.S., Madsen M., Rosdahl N., Konradsen H.B., Storm H.H., Melbye M. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N. Engl. J. Med. 2003, 349:1324.
23. Hochberg D., Middeldorp J.M., Catalina M., Sullivan J.L., Luzuriaga K., Thorley-Lawson D.A. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:239.
24. Huntington N.D., Legrand N., Alves N.L., Jaron B., Weijer K., Plet A., Corcuff E., Mortier E., Jacques Y., Spits H., Di Santo J.P. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 2009, 206:25.
25. null mice. Blood 2005, 106:1565.
26. + cells with Epstein-Barr virus. J. Virol. 2004, 78:13891.
27. Jaiswal S., Pazoles P., Woda M., Shultz L.D., Greiner D.L., Brehm M.A., Mathew A. Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice. Immunology 2012, 136:334.
28. Kutok J.L., Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 2006, 1:375.
29. Kuwana Y., Takei M., Yajima M., Imadome K., Inomata H., Shiozaki M., Ikumi N., Nozaki T., Shiraiwa H., Kitamura N., Takeuchi J., Sawada S., Yamamoto N., Shimizu N., Ito M., Fujiwara S. Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS ONE 2011, 6:e26630.
30. Laichalk L.L., Thorley-Lawson D.A. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J. Virol. 2005, 79:1296.
31. Legrand N., Weijer K., Spits H. Experimental models to study development and function of the human immune system in vivo. J. Immunol. 2006, 176:2053.
32. Leung C., Chijioke O., Gujer C., Chatterjee B., Antsiferova O., Landtwing V., McHugh D., Raykova A., Münz C. Infectious diseases in humanized mice. Eur. J. Immunol. 2013, 43:2246.
33. Leung C.S., Maurer M.A., Meixlsperger S., Lippmann A., Cheong C., Zuo J., Haigh T.A., Taylor G.S., Münz C. Robust T cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. Blood 2013, 121:1584.
34. Lim W.H., Kireta S., Russ G.R., Coates P.T. Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice. Blood 2006, 109:1043.
35. Lotz M., Tsoukas C.D., Fong S., Carson D.A., Vaughan J.H. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur. J. Immunol. 1985, 15:520.
36. Luzuriaga K., Sullivan J.L. Infectious mononucleosis. N. Engl. J. Med. 2010, 362:1993.
37. Ma S.D., Hegde S., Young K.H., Sullivan R., Rajesh D., Zhou Y., Jankowska-Gan E., Burlingham W.J., Sun X., Gulley M.L., Tang W., Gumperz J.E., Kenney S.C. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J. Virol. 2011, 85:165.
38. bright subset. Blood 2013, 121:2669.
39. May K.F., Roychowdhury S., Bhatt D., Kocak E., Bai X.F., Liu J.Q., Ferketich A.K., Martin E.W., Caligiuri M.A., Zheng P., Liu Y. Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies. Blood 2005, 105:1114.
40. + dendritic cells produce prominent amounts of IFN-alpha after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood 2013, 121:5034.
41. Melkus M.W., Estes J.D., Padgett-Thomas A., Gatlin J., Denton P.W., Othieno F.A., Wege A.K., Haase A.T., Garcia J.V. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 2006, 12:1316.
42. Miller G., Lipman M. Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus. J. Exp. Med. 1973, 138:1398.
43. Moghaddam A., Rosenzweig M., Lee-Parritz D., Annis B., Johnson R.P., Wang F. An animal model for acute and persistent Epstein-Barr virus infection. Science 1997, 276:2030.
44. Münz C., Lünemann J.D., Getts M.T., Miller S.D. Antiviral immune responses: triggers of or triggered by autoimmunity?. Nat. Rev. Immunol. 2009, 9:246.
45. Nielsen T., Rostgaard K., Askling J., Steffensen R., Oturai A., Jersild C., Koch-Henriksen N., Sorensen P., Hjalgrim H. Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult. Scler. 2009, 15:431.
46. Nochi T., Denton P.W., Wahl A., Garcia J.V. Cryptopatches are essential for the development of human GALT. Cell Rep. 2013, 3:1874.
47. Ohashi M., Fogg M.H., Orlova N., Quink C., Wang F. An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection. PLoS Pathog. 2012, 8:e1003095.
48. Orlova N., Fogg M.H., Carville A., Wang F. Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to Epstein-Barr virus infection. Clin. Vaccine Immunol. 2011, 18:1427.
49. + T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans. J. Virol. 2011, 85:12821.
50. Rivailler P., Cho Y.G., Wang F. Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J. Virol. 2002, 76:12055.
51. Rivailler P., Carville A., Kaur A., Rao P., Quink C., Kutok J.L., Westmoreland S., Klumpp S., Simon M., Aster J.C., Wang F. Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host. Blood 2004, 104:1482.
52. Rongvaux A., Takizawa H., Strowig T., Willinger T., Eynon E.E., Flavell R.A., Manz M.G. Human hemato-lymphoid system mice: current use and future potential for medicine. Annu. Rev. Immunol. 2013, 31:635.
53. Sato K., Misawa N., Nie C., Satou Y., Iwakiri D., Matsuoka M., Takahashi R., Kuzushima K., Ito M., Takada K., Koyanagi Y. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 2011, 117:5663.
54. Shannon-Lowe C., Rowe M. Epstein Barr virus entry; kissing and conjugation. Curr. Opin. Virol. 2014, 4C:78.
55. Shultz L.D., Lyons B.L., Burzenski L.M., Gott B., Chen X., Chaleff S., Kotb M., Gillies S.D., King M., Mangada J., Greiner D.L., Handgretinger R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 2005, 174:6477.
56. null humanized mice. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13022.
57. Strowig T., Gurer C., Ploss A., Liu Y.F., Arrey F., Sashihara J., Koo G., Rice C.M., Young J.W., Chadburn A., Cohen J.I., Münz C. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 2009, 206:1423.
58. Strowig T., Chijioke O., Carrega P., Arrey F., Meixlsperger S., Ramer P.C., Ferlazzo G., Münz C. Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 2010, 116:4158.
59. Thacker E.L., Mirzaei F., Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol. 2006, 59:499.
60. Thorley-Lawson D.A., Allday M.J. The curious case of the tumour virus: 50years of Burkitt's lymphoma. Nat. Rev. Microbiol. 2008, 6:913.
61. Thorley-Lawson D.A., Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 2004, 350:1328.
62. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J.C., Lanzavecchia A., Manz M.G. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104.
63. Tsai M.H., Raykova A., Klinke O., Bernhardt K., Gartner K., Leung C.S., Geletneky K., Sertel S., Münz C., Feederle R., Delecluse H.J. Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep. 2013, 5:458.
64. Tsao S.W., Tsang C.M., Pang P.S., Zhang G., Chen H., Lo K.W. The biology of EBV infection in human epithelial cells. Semin. Cancer Biol. 2012, 22:137.
65. Usherwood E.J., Meadows S.K., Crist S.G., Bellfy S.C., Sentman C.L. Control of murine gammaherpesvirus infection is independent of NK cells. Eur. J. Immunol. 2005, 35:2956.
66. Virgin H.W., Speck S.H. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 1999, 11:371.
67. White R.E., Ramer P.C., Naresh K.N., Meixlsperger S., Pinaud L., Rooney C., Savoldo B., Coutinho R., Bodor C., Gribben J., Ibrahim H.A., Bower M., Nourse J.P., Gandhi M.K., Middeldorp J., Cader F.Z., Murray P., Münz C., Allday M.J. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J. Clin. Invest. 2012, 122:1487.
68. Willinger T., Rongvaux A., Strowig T., Manz M.G., Flavell R.A. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol. 2011, 32:321.
69. Yajima M., Imadome K., Nakagawa A., Watanabe S., Terashima K., Nakamura H., Ito M., Shimizu N., Honda M., Yamamoto N., Fujiwara S. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 2008, 198:673.
70. Yajima M., Imadome K., Nakagawa A., Watanabe S., Terashima K., Nakamura H., Ito M., Shimizu N., Yamamoto N., Fujiwara S. T cell-mediated control of Epstein-Barr virus infection in humanized mice. J. Infect. Dis. 2009, 200:1611.
71. Young L.S., Rickinson A.B. Epstein-Barr virus: 40years on. Nat. Rev. Cancer 2004, 4:757.